Efficacy and safety of antidepressants for children and adolescents. - Wikidata - awgldk - TriplyDB

Efficacy and safety of antidepressants for children and adolescents.

Efficacy and safety of antidepressants for children and adolescents.

http://www.wikidata.org/entity/Q34546991

about

Newer generation antidepressants for depressive disorders in children and adolescents Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents Rethinking childhood depression Family physicians' involvement and self-reported comfort and skill in care of children with behavioral and emotional problems: a population-based survey Perspectives on the efficacy of antidepressants for child and adolescent depression What are the public health effects of direct-to-consumer drug advertising?Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?Effects of chronic fluoxetine treatment on neurogenesis and tryptophan hydroxylase expression in adolescent and adult rats Increased response to a 5-HT challenge after discontinuation of chronic serotonin uptake inhibition in the adult and adolescent rat brain Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.The citalopram CIT-MD-18 pediatric depression trial: Deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance.Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial.Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.Making decisions about treatment for young people diagnosed with depressive disorders: a qualitative study of clinicians' experiences.Antidepressants and Suicide Risk: A Comprehensive Overview Child and adolescent mental health care in Dutch general practice: time trend analyses.Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review.Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials.Pediatric psychotropic polypharmacy Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report Suicide prevention is far more than a psychiatric business.How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?The Food and Drug Administration's deliberations on antidepressant use in pediatric patients.A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database Managing attention deficit/hyperactivity disorder: unmet needs and future directions Addressing risks to advance mental health research.The medicines for children agenda in the UK.Depression, antidepressants and suicidality: a critical appraisal.Should young people be given antidepressants? No.Should young people be given antidepressants? Yes.Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1).The epidemiology of psychotropic drug use in children and adolescents.The risks and benefits of antidepressant treatment for youth depression.Mother's country of birth and prescription of psychotropic medication in Swedish adolescents: a life course approach Lamotrigine in adolescent mood disorders: a retrospective chart review Controversy revisited: Selective serotonin reuptake inhibitors in paediatric depression.How to use medicines in children: principles of paediatric clinical pharmacology.Outside the Black Box: Re-assessing Pediatric Antidepressant Prescription New-generation antidepressants, suicide and depressed adolescents: how should clinicians respond to changing evidence?

P2860

Q24202873-F47B31FD-69F4-4A5E-BBF2-B9B172682955 Q24244127-2A1A1F79-037E-4F5F-A6D4-EC433F57F284 Q24558773-BD93386B-4E21-4390-86E0-585A45C2C41B Q24792871-8D312C97-7E49-491F-A1FC-3907DFA663F4 Q24812722-4DD71F81-50B3-4480-9B71-BE7005E84332 Q28195995-80EEC0B1-5176-4F43-AD26-E78ADC2992CF Q28262885-E5843683-EDE4-482D-A53F-3828791D1F03 Q28279067-FDC200EF-06CD-47C0-9E83-6AFF5E74DAE2 Q28538828-172CCD7C-CE56-49C5-9731-3BE766F3E2FE Q28539770-830EC215-EFD7-466E-9C48-108349461B4A Q30547324-9C33B064-A75D-4196-BC07-19E06F7917A1 Q31095928-AA0F70A9-3756-4F3E-B475-6E9B8C72CB92 Q33317432-28CCD40C-783D-4D8C-8072-E0DCE4DBC560 Q33350235-A122DF60-C8F6-4DBA-974B-00A8F3C9F65F Q33645395-5E3734DA-852C-40C5-ACE0-835715057B56 Q33664712-6813DED1-BB1C-4696-B4A3-B0CB5144C414 Q34088641-865AF94D-1259-43D1-80F0-A04251B9DCD9 Q34318546-905B8A40-83D9-473E-9164-CEDB1ED2C3C9 Q34353845-C736AA63-FAEC-434A-A47C-20E312570674 Q34396728-6FDCD39E-ED5E-4F54-8396-49AF5633BFAC Q34464274-1F6667C3-1212-4339-85F0-32E0C626B7C9 Q34481967-B66BAC8F-DA47-4314-B702-974E2678BCC6 Q34575698-CC775864-E968-403D-9026-4B3860A137B8 Q34998784-A8789338-DBEB-4145-9374-77D51813D93B Q35277907-ED3EDC60-3334-48B8-BC18-F4D03F56BFE1 Q35575707-B28E254C-866E-472A-8B3F-C64C2E861E0D Q35786243-C7FBFEFA-BD6C-4AA5-85C0-DDC388C861B2 Q35827708-99FD8F44-90B6-4411-BED9-1C13520FB549 Q36028253-B48EA46F-CAE3-4D32-BAAA-AEBCF45BCF3E Q36059883-1EFC792B-D0C1-4B6F-9C66-CF61D5AC3FA8 Q36059945-12D6D70B-51A7-4A13-8D46-983944F54F7E Q36104338-9A26BA03-422C-4801-BADF-46367EC8CC73 Q36272506-04905EEC-39C4-4B99-979E-F5BB5D3A019D Q36276293-12B86340-65F4-498F-963A-0A3470E0D537 Q36306919-50B37263-67D3-4D02-8C75-808BBD5F636C Q36511705-CF79247B-4744-461C-BAA6-902E69FFA1CE Q36637677-9ADD8CA4-B6C4-4584-98CB-71933548971B Q36742446-FD4880DB-33D4-4794-A5E0-8340224CA5F1 Q37112065-81D2EE73-D6AA-4BD4-96AB-73C42D256D27 Q37157631-023235FD-DE9C-4DA7-BC94-7B9ABD6CF828

P2860

Efficacy and safety of antidepressants for children and adolescents.

http://www.wikidata.org/entity/Q34546991

description

2004 nî lūn-bûn

@nan

2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Efficacy and safety of antidepressants for children and adolescents.

@ast

Efficacy and safety of antidepressants for children and adolescents.

@en

Efficacy and safety of antidepressants for children and adolescents.

@nl

type

label

Efficacy and safety of antidepressants for children and adolescents.

@ast

Efficacy and safety of antidepressants for children and adolescents.

@en

Efficacy and safety of antidepressants for children and adolescents.

@nl

prefLabel

Efficacy and safety of antidepressants for children and adolescents.

@ast

Efficacy and safety of antidepressants for children and adolescents.

@en

Efficacy and safety of antidepressants for children and adolescents.

@nl

P1433

Q34546991-4E189F9F-3D29-4FC0-9431-B1383C4C415F

P1476

Q34546991-7DDC3DDD-D419-4849-A07B-40686E030EE3

P2093

Q34546991-3F5195BA-66C4-41B8-9F11-4581ADBBCC01

Q34546991-4123FD63-CBD7-445E-8374-6D7A320075AF

Q34546991-50008526-EC57-4CDE-9BCF-64917B738BC0

Q34546991-62D0882A-D1D0-437F-B3C8-DA1317DABEE8

Q34546991-72A7FF60-B464-4B6D-9DC9-CBB065C4BBAF

Q34546991-B9B7E00F-1AED-4E9E-9721-5476216E2619

P2860

Q34546991-0F73B38F-E034-4B0E-8C5E-45FBAB02C8B9

Q34546991-235F9A5D-4458-4224-B1A3-F8CADBC79A70

Q34546991-2B480168-BF66-45EE-AB24-AA095CE048CC

Q34546991-49364D96-EC55-4A5A-86AF-01570F1A76A2

Q34546991-520FDDB8-AC7D-44A3-A988-AE524E5680E2

Q34546991-5D4D6F33-E40F-48A7-A4D1-4DE255171380

Q34546991-5FEEAA57-588A-49C8-AC8E-C6D117990E56

Q34546991-6B6DA61C-309C-4F0A-AD70-6241522702A2

Q34546991-908A8413-038C-4164-92B9-7C7E44C9B29C

Q34546991-9B450905-08FB-423C-A807-03115D679CBD

P304

Q34546991-58A2D37F-AA29-4A4B-A02D-9DD82C6AFBD0

P31

Q34546991-E99ABA67-4F20-4EB5-8FDE-36B721E43FD4

P356

Q34546991-1868F659-61B7-48C2-86AD-5A33E8B51E8C

P407

Q34546991-450077DB-C7B5-4E29-B543-3A40E4785CE5

P433

Q34546991-233FFE88-DF8E-4B46-999B-3B866C5A143E

P478

Q34546991-53C30A0C-F960-4EDD-B44C-9ABD22CAE32B

P577

Q34546991-660FD803-8AD9-436C-B15C-E99C021F4ED5

P5875

Q34546991-0D4D259A-2D24-43E4-8EC6-FD7E7013F66D

P698

Q34546991-9D0155E9-F1AC-4956-9DFD-9561BDCC83CF

P921

Q34546991-61869AC5-794E-4B3A-AC31-2FF13E014006

P932

Q34546991-EB581176-4EEE-4B1C-AF55-7B12BF10AC5E

P356

BMJ.328.7444.879

P1433

P1476

Efficacy and safety of antidepressants for children and adolescents.

@en

P2093

Anne L Tonkin

http://www.w3.org/2001/XMLSchema#string

Christopher J Doecke

http://www.w3.org/2001/XMLSchema#string

David B Menkes

http://www.w3.org/2001/XMLSchema#string

Jon N Jureidini

http://www.w3.org/2001/XMLSchema#string

Michelle M Haby

http://www.w3.org/2001/XMLSchema#string

Peter R Mansfield

http://www.w3.org/2001/XMLSchema#string

P2860

Active placebos versus antidepressants for depression

Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder

Timing of new black box warnings and withdrawals for prescription medications

Placebos, drug effects, and study design: a clinician's guide.

Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.

Clinical practice guidelines for depression in young people: are the treatment recommendations outdated?

Concomitant psychotropic medication for youths.

Antidepressants and adverse effects in young patients: uncovering the evidence.

Facing the evidence: antidepressant treatment in children and adolescents.

P304

879-883

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.328.7444.879

http://www.w3.org/2001/XMLSchema#string

P407

P433

7444

http://www.w3.org/2001/XMLSchema#string

P478

328

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232262694

http://www.w3.org/2001/XMLSchema#string

P698

15073072

http://www.w3.org/2001/XMLSchema#string

P921

P932

387483

http://www.w3.org/2001/XMLSchema#string